EyePoint Pharmaceuticals ...

6.32
-0.22 (-3.36%)
At close: Apr 25, 2025, 3:59 PM
6.34
0.40%
After-hours: Apr 25, 2025, 04:35 PM EDT

EyePoint Pharmaceuticals Revenue Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Sep 30, 2018
License And Collaboration Agreement Revenue 9.56M 7.78M 14.14M 3.6M 34K 202K 7.27M 7.42M 4.61M 11.19M 8.59M 4.17M 3.03M 6.68M 5.76M 3.71M 4.74M 55K 6.71M 543K 430K
License And Collaboration Agreement Revenue Growth +22.86% -44.95% +293.02% +10479.41% -83.17% -97.22% -1.99% +60.94% -58.78% +30.26% +106.12% +37.54% -54.66% +16.01% +55.37% -21.86% +8523.64% -99.18% +1134.81% +26.28% n/a
Product Revenue 664K 1.07M 816K 5.27M 7.39M 474K n/a n/a n/a 5.83M 3.93M 8.74M n/a 3.96M 3.47M 2.88M n/a n/a 6.71M n/a n/a
Product Revenue Growth -37.83% +30.88% -84.52% -28.69% +1459.92% n/a n/a n/a n/a +48.55% -55.05% n/a n/a +14.20% +20.39% n/a n/a n/a n/a n/a n/a
Royalty Revenue 299K 627K 249K 235K 255K 9.02M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Royalty Revenue Growth -52.31% +151.81% +5.96% -7.84% -97.17% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Y U T I Q Product Revenue 700K 1.1M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Y U T I Q Product Revenue Growth -36.36% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Jun 30, 2018 Jun 30, 2017 Jun 30, 2016 Jun 30, 2015
China Revenue 823K 851K 11.71M 1.12M 2.86M 7.44M 1.52M 26.46M
China Revenue Growth -3.29% -92.73% +944.87% -60.82% -61.54% +389.41% -94.26% n/a
United States Revenue 40.48M 35.99M 22.62M 19.14M n/a n/a n/a n/a
United States Revenue Growth +12.48% +59.07% +18.18% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Period Ending Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 12.99M 12.8M 14.11M 11.43M 11.04M 14.34M 14.98M 14.41M 15.23M 15.44M 15.24M 17.03M 13.43M 11.84M 10.77M 11.59M 11.06M 10.88M 12.48M 11.55M 12.14M 12.1M 11.92M 9.27M 7.81M 5.73M 2.28M 2.47M 2.57M 2.62M 2.43M 2.9M 3.29M 2.66M 2.35M 2.04M 1.97M 2.41M 2.04M
Selling, General, and Administrative Revenue Growth +1.52% -9.26% +23.39% +3.61% -23.07% -4.24% +3.94% -5.37% -1.37% +1.31% -10.49% +26.75% +13.43% +9.92% -7.02% +4.72% +1.69% -12.85% +8.11% -4.90% +0.36% +1.49% +28.63% +18.71% +36.20% +151.29% -7.73% -3.89% -1.98% +8.16% -16.34% -11.72% +23.68% +13.21% +14.83% +3.81% -18.37% +18.13% n/a
Research and Development Revenue 29.54M 29.82M 30.14M 17.95M 17.36M 15.73M 13.62M 15.54M 11.16M 12.99M 9.95M 8.92M 8.5M 5.61M 5.48M 5.21M 4.09M 3.28M 4.85M 4.13M 3.48M 3.96M 3.8M 4.18M 6.23M 4.76M 3.33M 4.27M 3.82M 4.21M 3.32M 3.17M 4.18M 4.1M 3.07M 3.72M 3.48M 3.2M 3.34M
Research and Development Revenue Growth -0.94% -1.05% +67.90% +3.39% +10.38% +15.51% -12.38% +39.25% -14.09% +30.64% +11.52% +4.94% +51.61% +2.30% +5.26% +27.26% +24.85% -32.50% +17.45% +18.60% -11.91% +4.16% -9.14% -32.95% +30.81% +43.31% -22.11% +11.78% -9.35% +26.74% +5.02% -24.25% +1.80% +33.51% -17.39% +6.86% +8.88% -4.22% n/a
Sales and Marketing Revenue 24K 50K 6K 185K 479K 5.29M 5.74M 5.92M 6.02M 6.88M 6.69M 7.81M 7.37M 6.66M 5.66M 5.81M 5.27M 6.09M 8.13M 7.4M 7.78M 7.28M 7.31M 4.53M 3.65M 1.51M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth -52.00% +733.33% -96.76% -61.38% -90.94% -7.83% -3.01% -1.68% -12.60% +2.84% -14.31% +5.93% +10.74% +17.67% -2.60% +10.27% -13.47% -25.06% +9.81% -4.87% +6.78% -0.37% +61.46% +24.19% +141.14% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a